S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Gary Payton II Joins Valor to Advance Athlete Recovery Tech

With lower-extremity injuries in the NBA hitting record highs, Golden State Warriors guard Gary Payton II has signed on as Chief Athletic Ambassador for Valor, the sports medicine division of Vector Science & Therapeutics. The move aims to integrate elite athlete feedback into non-addictive pain management and tissue repair platforms.

Gary Payton II Joins Valor to Advance Athlete Recovery Tech
Photo: Bio & News

The partnership arrives as professional basketball grapples with a steep rise in soft tissue damage. Data from May 2026 indicates that calf injuries reached 86 this season, a sharp increase from 18 during the 2010-11 campaign. By leveraging his experience as a high-level defender, Payton II plans to advocate for recovery alternatives that avoid the long-term consequences often associated with traditional pain treatments.

"Injury and pain are part of the game," said Payton II. "What you use to manage them doesn't have to come with consequences you'll spend the rest of your life dealing with." Valor President Darryl Drake Jr. noted that the guard’s active participation in the league provides a unique, firsthand perspective critical to the company's research into transdermal peptide delivery and biomechanical interventions. Beyond his work with Valor, Payton II continues to lead the GPII Foundation, which provides educational resources and dyslexia support for children.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!